Xlife Sciences AG
SIX:XLS
Cash Flow Statement
Cash Flow Statement
Xlife Sciences AG
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
21
|
14
|
53
|
46
|
9
|
11
|
9
|
16
|
29
|
25
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
16
|
24
|
16
|
16
|
16
|
16
|
|
| Other Non-Cash Items |
(24)
|
(17)
|
(48)
|
(43)
|
(28)
|
(38)
|
(20)
|
(25)
|
(42)
|
(38)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
1
|
(9)
|
(8)
|
(1)
|
(0)
|
(5)
|
(5)
|
(3)
|
(3)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(2)
-439%
|
(4)
-100%
|
(5)
-26%
|
(5)
+16%
|
(4)
+14%
|
0
N/A
|
2
+1 014%
|
(0)
N/A
|
(0)
+46%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Other Items |
(4)
|
(6)
|
(6)
|
(3)
|
(2)
|
2
|
(1)
|
(4)
|
(4)
|
(5)
|
|
| Cash from Investing Activities |
(4)
N/A
|
(6)
-61%
|
(7)
-13%
|
(4)
+43%
|
(2)
+58%
|
2
N/A
|
(1)
N/A
|
(4)
-338%
|
(4)
+10%
|
(5)
-36%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
7
|
14
|
9
|
7
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
4
|
6
|
|
| Other |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
6
N/A
|
13
+102%
|
9
-34%
|
6
-32%
|
5
-22%
|
0
-100%
|
1
+11 097%
|
2
+154%
|
4
+104%
|
6
+30%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
2
N/A
|
5
+112%
|
(3)
N/A
|
(4)
-31%
|
(2)
+52%
|
(2)
+2%
|
(0)
+100%
|
(0)
-18 322%
|
(0)
+72%
|
(0)
+58%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(1)
N/A
|
(2)
-272%
|
(6)
-138%
|
(7)
-20%
|
(5)
+30%
|
(4)
+16%
|
0
N/A
|
2
+1 364%
|
(0)
N/A
|
(0)
+48%
|
|